Skip to content

Insider · CIK 0001283215

Joseph M Patti

director

Files at ARMP (Armata Pharmaceuticals, Inc.). First filing -, latest -.

Joseph M Patti files SEC Form 4 as director at ARMP (Armata Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Joseph M Patti has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 9, 2026ARMP
Armata Pharmaceuticals, Inc.
AGrant or award
Stock Options (Right to Buy)derivative
+25,640$0.00$025,640Mar 11, 2026
Feb 5, 2025ARMP
Armata Pharmaceuticals, Inc.
AGrant or award
Stock Options (Right to Buy)derivative
+54,343$0.00$054,343Feb 7, 2025

Questions about Joseph M Patti

Answered from the filings on this page, as of the latest one.

Is Joseph M Patti buying or selling?

Joseph M Patti has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Joseph M Patti's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph M Patti has 0.

Where does Joseph M Patti file Form 4?

Joseph M Patti has filed Form 4 at ARMP (Armata Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Joseph M Patti: insider trades and track record | InsiderTell